Furthermore, gestational T treatment leads to maternal hyperinsulinemia and disrupts insulin signaling in fetal metabolic tissues [21] during critical periods of development that encompass pituitary gonadotroph differentiation [22]. Here, INS is linked to Hyperinsulinemia.